...
首页> 外文期刊>Journal of Medicinal Chemistry >Alkylsulfanyl-1,2,4-triazoles, a New Class of allosteric valosine containing protein inhibitors. Synthesis and structure-activity relationships
【24h】

Alkylsulfanyl-1,2,4-triazoles, a New Class of allosteric valosine containing protein inhibitors. Synthesis and structure-activity relationships

机译:烷基硫烷基1,2,4-三唑,一种新型的变构缬氨酸,含蛋白质抑制剂。合成与构效关系

获取原文
获取原文并翻译 | 示例
           

摘要

Valosine containing protein (VCP), also known as p97, is a member of AAA ATPase family that is involved in several biological processes and plays a central role in the ubiquitin-mediated degradation of misfolded proteins. VCP is an ubiquitously expressed, highly abundant protein and has been found overexpressed in many tumor types, sometimes associated with poor prognosis. In this respect, VCP has recently received a great deal of attention as a potential new target for cancer therapy. In this paper, the discovery and structure-activity relationships of alkylsulfanyl-1,2,4-triazoles, a new class of potent, allosteric VCP inhibitors, are described. Medicinal chemistry manipulation of compound 1, identified via HTS, led to the discovery of potent and selective inhibitors with submicromolar activity in cells and clear mechanism of action at consistent doses. This represents a first step toward a new class of potential anticancer agents.
机译:含缬氨酸的蛋白质(VCP),也称为p97,是AAA ATPase家族的成员,该家族参与多个生物学过程,并在遍在蛋白介导的错折叠蛋白降解中发挥重要作用。 VCP是一种普遍表达的,高度丰富的蛋白质,已发现在许多肿瘤类型中过表达,有时与不良预后有关。在这方面,VCP最近作为癌症治疗的潜在新靶标受到了广泛关注。在本文中,描述了新型强效变构VCP抑制剂烷基硫烷基-1,2,4-三唑的发现及其与构效关系。通过HTS鉴定的化合物1的药物化学操作导致发现了有效和选择性的抑制剂,这些抑制剂在细胞中具有亚微摩尔活性,并且在恒定剂量下具有明确的作用机理。这代表了迈向新型潜在抗癌药的第一步。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号